Cargando…
Targeting NFκB signaling in GD2(+) BCSCs
Autores principales: | Nguyen, Khoa, Battula, V. Lokesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5611972/ https://www.ncbi.nlm.nih.gov/pubmed/28858852 http://dx.doi.org/10.18632/aging.101274 |
Ejemplares similares
-
IKK inhibition by BMS-345541 suppresses breast tumorigenesis and metastases by targeting GD2(+) cancer stem cells
por: Battula, Venkata Lokesh, et al.
Publicado: (2017) -
Anti-GD2 antibody dinutuximab inhibits triple-negative breast tumor growth by targeting GD2(+) breast cancer stem-like cells
por: Ly, Stanley, et al.
Publicado: (2021) -
Cytokines, breast cancer stem cells (BCSCs) and chemoresistance
por: Chen, Weilong, et al.
Publicado: (2018) -
Heterogeneity of BCSCs contributes to the metastatic organotropism of breast cancer
por: Wang, Cenzhu, et al.
Publicado: (2021) -
Expression of ganglioside GD2, reprogram the lipid metabolism and EMT phenotype in bladder cancer
por: Vantaku, Venkatrao, et al.
Publicado: (2017)